These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4568899)

  • 21. [Thiocarlide. Attempt of an evaluation].
    Protivinsky R
    Ther Ggw; 1969 Oct; 108(10):1410-1 passim. PubMed ID: 4908478
    [No Abstract]   [Full Text] [Related]  

  • 22. [THE EFFECTIVENESS OF TREATMENT WITH COMBINED ISONIAZID AND PARA-AMINOSALICYLIC ACID (PAS) AND WITH ISONIAZID AND PARA-AMINOBENZOIC ACID (PABA) IN EXPERIMENTAL TUBERCULOSIS IN GUINEA PIGS].
    VITOLO A
    Riv Patol Clin; 1963 Oct; 18():621-8. PubMed ID: 14112642
    [No Abstract]   [Full Text] [Related]  

  • 23. [Intermittent treatment and simplified continuous treatment of newly-detected pulmonary tuberculosis with first-line drugs and limited PAS administration. I. Methods and results].
    Stopczyk J; Niemirowska H; Pecyna-Sielewicz J; Janowiec M; Banaszkiewicz H; Czerwiński Z; Królikowska H; Krahowska M; Malecki S; Pezińska Z; Pilch Z; Przemyska B; Szustrowa I; Wardowa A
    Gruzlica; 1973 Jul; 41(7):755-64. PubMed ID: 4730976
    [No Abstract]   [Full Text] [Related]  

  • 24. [Five year follow-up study on the short-course chemotherapy for pulmonary tuberculosis in Niigata Prefecture].
    Hashimoto T; Shimao T; Aoki M; Misawa H; Takasawa N; Shiozawa S
    Kekkaku; 1984 Jun; 59(6):369-76. PubMed ID: 6492547
    [No Abstract]   [Full Text] [Related]  

  • 25. Spread of drug-resistant tubercle bacilli.
    Brander E; Aho K; Pätiälä J
    Am Rev Respir Dis; 1968 Sep; 98(3):407-15. PubMed ID: 4970549
    [No Abstract]   [Full Text] [Related]  

  • 26. Five cases of child tuberculosis caused by strains primarily resitant to all three main anti-tuberculosis drugs.
    Brander E; Aho K; Wasz-Höckert O
    Scand J Respir Dis; 1967; 48(1):76-80. PubMed ID: 4964559
    [No Abstract]   [Full Text] [Related]  

  • 27. [Combined antitubercular treatment of pulmonary tuberculosis in adults].
    Böszörményi M
    Orv Hetil; 1970 Mar; 111(11):603-8. PubMed ID: 4911914
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of insulin on isoniazid and para-aminosalicylic acid metabolism in patients with pulmonary tuberculosis].
    Savula MM; Kiselova ES
    Probl Tuberk; 1974; (8):43-6. PubMed ID: 4409368
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical picture of erythema fixum generalisatum caused by PAS hypersensitivity observed in 41-year-old male with pulmonary tuberculosis after a prolonged treatment with antitubercular agents (INH and PAS)].
    Laszczka C
    Gruzlica; 1965 Oct; 33(10):935-7. PubMed ID: 4222649
    [No Abstract]   [Full Text] [Related]  

  • 30. [Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples].
    Romano S; Grella G
    Rass Int Clin Ter; 1966 Dec; 46(23):1311-6. PubMed ID: 5997869
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug-resistant pulmonary tuberculosis in Norway. Preliminary report.
    Bjartveit K
    Scand J Respir Dis Suppl; 1969; 69():21-2. PubMed ID: 5264216
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug therapy of pulmonary tuberculosis].
    Ludes H
    Dtsch Med Wochenschr; 1972 Feb; 97(8):289-91. PubMed ID: 5058425
    [No Abstract]   [Full Text] [Related]  

  • 33. [Active fraction of isonicotinic acid hydrazide in the blood of tuberculosis patients during its combined use with PAS].
    Dudchik GKh; Bilyk MA
    Vrach Delo; 1981 Feb; (2):77-8. PubMed ID: 7222619
    [No Abstract]   [Full Text] [Related]  

  • 34. [Question of bactericidal effect of a combination of maximally tolerable doses of INH, Myambutol and Rifadin on experimental tuberculosis].
    Djurisić M; Davidović C; Leposavić M; Jovancvić M; Marković L; Popović S
    Plucne Bolesti Tuberk; 1973; 25(3):251-6. PubMed ID: 4210992
    [No Abstract]   [Full Text] [Related]  

  • 35. [Problems related to ambulatory treatment with isoniazid and aminosalicylic acid].
    Waisbich E; de Barros RF
    Hospital (Rio J); 1967 Nov; 72(5):1547-50. PubMed ID: 5307829
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
    Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemoprophylaxis in inactive tuberculosis: long-term evaluation of a Canadian trial.
    Grzybowski S; Ashley MJ; Pinkus G
    Can Med Assoc J; 1976 Apr; 114(7):607-11. PubMed ID: 816447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reasons for failures in chemotherapy of tuberculosis].
    Dissmann E
    Beitr Klin Erforsch Tuberk Lungenkr; 1968; 138(1):17-24. PubMed ID: 5728639
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative trial of thiacetazone with isoniazid and paraaminosalicyclic acid (PAS) with isoniazid in the treatment of pulmonary tuberculosis in Nigerians.
    Onadeko BO; Sofowora EO
    J Trop Med Hyg; 1975 Sep; 78(9):201-5. PubMed ID: 57244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of efficiency of large and small doses of isoniazid in combined treatment in pulmonary tuberculosis].
    Mysakowska H; Grodzki S; Przemyska B; Szarewicz W; Srednicka D
    Pol Tyg Lek; 1965 Apr; 20(16):562-4. PubMed ID: 5834844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.